Editorial p801 NINDS at the forefront of epilepsy research for 75 years The Lancet Neurology + +(¡!) + +...

Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00269-8/abstract?utm_campaign=infocusalerts-neurology&utm_medium=email&dgcid=hubspot_email_infocusalerts-neurology_feature&_hsenc=p2ANqtz-_x21S2JeJ_ykFn_JuQCI3G_HsJd9O_oqtcs-tYXbU6iLlV2cjTXVt6ZVU3vQeZFMtoub4OL1r5M6hhGJLIKnSF_fnVoQ&_hsmi=386748627&utm_content=386532796&utm_source=hs_email Innate immunity regulation of brain health: a webinar from The Lancet Group and Cell Press About Innate immunity is the body's first line of defence against infections and injury. In the central nervous system, it is crucial for protecting against pathogens and clearing damaged tissue, while maintaining neural function. However, chronic innate immune activation can contribute to neuroinflammation. This joint webinar between The Lancet Group and Cell Press will: Provide an accessible overview of the importance of innate immunity in the development of neurological diseases, including interferonopathies, multiple sclerosis, and neurodegenerative diseases. Review potential therapeutic targets to protect neurons from inflammation-induced neurodegeneration in multiple sclerosis. Discuss common features of innate immunity across neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and the neuroimmune interactions that can propagate neurotoxicity. Examine the triggers of these mechanisms in neurons and glia. When Thursday, 20/11/2025 · 10:00 Atlantic Time (Canada) (GMT -4:00) https://www.bigmarker.com/lancet-webinars/innate-immunity-regulation-of-brain-health-a-webinar-from-the-lancet-group-and-cell-press?utm_bmcr_source=hubspot_email_infocusalerts-neurology&_hsenc=p2ANqtz-9TrFzB7s7F8g-5QluT7AFREqo7OuJaboO01tGq6lVxu25otcBkpwv79uS6Bv6CWGz6G9Y_nJYqXHde2wOoFHb4_yBHGw&_hsmi=386748627 Shiv Saidha on recent updates in the diagnosis of multiple sclerosis September 17, 2025 • The Lancet Group https://thelancetneurology.buzzsprout.com/1391383/episodes/17853972-shiv-saidha-on-recent-updates-in-the-diagnosis-of-multiple-sclerosis?utm_campaign=infocusalerts-neurology&utm_medium=email&_hsenc=p2ANqtz-9JEkUxTpF5yUcjCZtfRiMR-BCPz8AbQuQ-m2f16kd38XrDBNttKJiHjq06Cqhs1zRKL66iWS8AhF9TpBGqLc78s3mdKw&_hsmi=386748627&utm_content=386532796&utm_source=hs_email Editorial p801 NINDS at the forefront of epilepsy research for 75 years The Lancet Neurology https://www.thelancet.com/journals/laneur/issue/vol24no10/PIIS1474-4422(25)X0010-7